Massimo Gion

发表

Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma.

O. Vinante, P. Boracchi, G. Gasparini, 1997, Journal of the National Cancer Institute.

Interchangeability and diagnostic accuracy of two assays for total and free prostate-specific antigen: two not always related items.

R. Dittadi, L. Peloso, M. Gion, 2007, The International journal of biological markers.

Immunohistochemical Expression of Vascular Endothelial Growth Factor and Microvessel Counting as Prognostic Indicators in Node-Negative Colorectal Cancer

R. Geffers, D. Katsaros, E. Diamandis, 2005, Tumor Biology.

Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma.

O. Vinante, P. Boracchi, G. Gasparini, 1997, Journal of the National Cancer Institute.

Relationship between cathepsin D and other pathological and biological parameters in 1752 patients with primary breast cancer.

G. Capitanio, R. Dittadi, M. Gion, 1995, European journal of cancer.

Dynamic use of tumor markers, rationale-clinical applications and pitfalls.

R. Dittadi, M. Gion, R. Mione, 1996, Anticancer research.

The tumour associated antigen CA15.3 in primary breast cancer. Evaluation of 667 cases.

M. Gion, O. Nascimben, M. Valsecchi, 1991, British Journal of Cancer.

Determination of ErbB2 protein in breast cancer tissues by different methods. Relationships with other biological parameters

G. Capitanio, R. Dittadi, M. Gion, 2005, Breast Cancer Research and Treatment.

Epidermal growth factor receptor in breast cancer. Comparison with non malignant breast tissue.

R. Dittadi, M. Gion, P. Donisi, 1993, British Journal of Cancer.

Comparison between Two Methods in the Determination of Circulating Chromogranin A in Neuroendocrine Tumors (NETs): Results of a Prospective Multicenter Observational Study

F. D. De Braud, R. Dittadi, M. Gion, 2005 .